Finkelstein DI - Search Results

1

Distribution of Parkinson's disease associated RAB39B in mouse brain tissue.

Gao Y, Wilson GR, Stephenson SEM, Oulad-Abdelghani M, Charlet-Berguerand N, Bozaoglu K, McLean CA, Thomas PQ, Finkelstein DI, Lockhart PJ. Gao Y, et al. Among authors: finkelstein di. Mol Brain. 2020 Mar 30;13(1):52. doi: 10.1186/s13041-020-00584-7. Mol Brain. 2020. PMID: 32228644 Free PMC article.

2

Dopamine D2 receptor knockout mice develop features of Parkinson disease.

Tinsley RB, Bye CR, Parish CL, Tziotis-Vais A, George S, Culvenor JG, Li QX, Masters CL, Finkelstein DI, Horne MK. Tinsley RB, et al. Among authors: finkelstein di. Ann Neurol. 2009 Oct;66(4):472-84. doi: 10.1002/ana.21716. Ann Neurol. 2009. PMID: 19847912

3

α-Synuclein transgenic mice reveal compensatory increases in Parkinson's disease-associated proteins DJ-1 and parkin and have enhanced α-synuclein and PINK1 levels after rotenone treatment.

George S, Mok SS, Nurjono M, Ayton S, Finkelstein DI, Masters CL, Li QX, Culvenor JG. George S, et al. Among authors: finkelstein di. J Mol Neurosci. 2010 Oct;42(2):243-54. doi: 10.1007/s12031-010-9378-1. Epub 2010 May 13. J Mol Neurosci. 2010. PMID: 20464527

4

Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export.

Lei P, Ayton S, Finkelstein DI, Spoerri L, Ciccotosto GD, Wright DK, Wong BX, Adlard PA, Cherny RA, Lam LQ, Roberts BR, Volitakis I, Egan GF, McLean CA, Cappai R, Duce JA, Bush AI. Lei P, et al. Among authors: finkelstein di. Nat Med. 2012 Jan 29;18(2):291-5. doi: 10.1038/nm.2613. Nat Med. 2012. PMID: 22286308

5

Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease.

Ayton S, Lei P, Duce JA, Wong BX, Sedjahtera A, Adlard PA, Bush AI, Finkelstein DI. Ayton S, et al. Among authors: finkelstein di. Ann Neurol. 2013 Apr;73(4):554-9. doi: 10.1002/ana.23817. Epub 2013 Feb 19. Ann Neurol. 2013. PMID: 23424051

6

Iron accumulation confers neurotoxicity to a vulnerable population of nigral neurons: implications for Parkinson's disease.

Ayton S, Lei P, Adlard PA, Volitakis I, Cherny RA, Bush AI, Finkelstein DI. Ayton S, et al. Among authors: finkelstein di. Mol Neurodegener. 2014 Jul 10;9:27. doi: 10.1186/1750-1326-9-27. Mol Neurodegener. 2014. PMID: 25011704 Free PMC article.

7

Serotonergic markers in Parkinson's disease and levodopa-induced dyskinesias.

Cheshire P, Ayton S, Bertram KL, Ling H, Li A, McLean C, Halliday GM, O'Sullivan SS, Revesz T, Finkelstein DI, Storey E, Williams DR. Cheshire P, et al. Among authors: finkelstein di. Mov Disord. 2015 May;30(6):796-804. doi: 10.1002/mds.26144. Epub 2015 Feb 4. Mov Disord. 2015. PMID: 25649148

8

Parkinson's disease iron deposition caused by nitric oxide-induced loss of β-amyloid precursor protein.

Ayton S, Lei P, Hare DJ, Duce JA, George JL, Adlard PA, McLean C, Rogers JT, Cherny RA, Finkelstein DI, Bush AI. Ayton S, et al. Among authors: finkelstein di. J Neurosci. 2015 Feb 25;35(8):3591-7. doi: 10.1523/JNEUROSCI.3439-14.2015. J Neurosci. 2015. PMID: 25716857 Free PMC article.

9

Type-1 interferons contribute to the neuroinflammatory response and disease progression of the MPTP mouse model of Parkinson's disease.

Main BS, Zhang M, Brody KM, Ayton S, Frugier T, Steer D, Finkelstein D, Crack PJ, Taylor JM. Main BS, et al. Glia. 2016 Sep;64(9):1590-604. doi: 10.1002/glia.23028. Epub 2016 Jul 12. Glia. 2016. PMID: 27404846

10

Ferroptosis and cell death mechanisms in Parkinson's disease.

Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S. Guiney SJ, et al. Among authors: finkelstein di. Neurochem Int. 2017 Mar;104:34-48. doi: 10.1016/j.neuint.2017.01.004. Epub 2017 Jan 9. Neurochem Int. 2017. PMID: 28082232 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page